Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer

por Reyes, D. K., Rowe, S. P., Schaeffer, E. M., Allaf, M. E., Ross, A. E., Pavlovich, C. P., Deville, C., Tran, P. T., Pienta, K. J.
Publicado 2020

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer

por Zhao, S G, Jackson, W C, Kothari, V, Schipper, M J, Erho, N, Evans, J R, Speers, C, Hamstra, D A, Niknafs, Y S, Nguyen, P L, Schaeffer, E M, Ross, A E, Den, R B, Klein, E A, Jenkins, R B, Davicioni, E, Feng, F Y
Publicado 2015

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk

por Ross, A E, Den, R B, Yousefi, K, Trock, B J, Tosoian, J, Davicioni, E, Thompson, D J S, Choeurng, V, Haddad, Z, Tran, P T, Trabulsi, E J, Gomella, L G, Lallas, C D, Abdollah, F, Feng, F Y, Klein, E A, Dicker, A P, Freedland, S J, Karnes, R J, Schaeffer, E M
Publicado 2016

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

por Tse, B W C, Volpert, M, Ratther, E, Stylianou, N, Nouri, M, McGowan, K, Lehman, M L, McPherson, S J, Roshan-Moniri, M, Butler, M S, Caradec, J, Gregory-Evans, C Y, McGovern, J, Das, R, Takhar, M, Erho, N, Alshalafa, M, Davicioni, E, Schaeffer, E M, Jenkins, R B, Ross, A E, Karnes, R J, Den, R B, Fazli, L, Gregory, P A, Gleave, M E, Williams, E D, Rennie, P S, Buttyan, R, Gunter, J H, Selth, L A, Russell, P J, Nelson, C C, Hollier, B G
Publicado 2017